Literature DB >> 23954595

Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study.

Yukiharu Todo1, Hyuck-Jae Choi, Sokbom Kang, Jae-Weon Kim, Joo-Hyun Nam, Hidemichi Watari, Akiko Tamakoshi, Noriaki Sakuragi.   

Abstract

OBJECTIVE: The aim of this study was to elucidate the significance of tumor volume as a risk factor for predicting lymph node metastasis.
METHODS: We applied the tumor volume index to the data that were collected for 327 Korean patients with endometrial cancer who underwent preoperative assessment including magnetic resonance imaging (MRI) and subsequent surgery including systematic lymphadenectomy. The volume index, which we previously reported in the literature, was defined as the product of maximum longitudinal diameter along the uterine axis, maximum anteroposterior diameter in a sagittal section image, and maximum horizontal diameter in a horizontal section image according to MRI data, from 425 Japanese women with endometrial cancer. Relationships between lymph node metastasis and results of preoperative examinations including volume index were analyzed by logistic regression analysis.
RESULTS: The prevalence of affected lymph nodes was 14.2%. Multivariate analysis showed that high-grade histology assessed by endometrial biopsy [odds ratio (OR); 2.9, 95% confidence interval (CI): 1.4-6.4], volume index (OR; 2.4, 95% CI: 1.1-5.3), node enlargement assessed by MRI (OR; 4.2, 95% CI: 1.4-13.2), and high serum cancer antigen (CA)125 level (OR; 3.6, 95% CI: 1.6-8.1) were significantly and independently related to lymph node metastasis. When volume index was excluded from the analysis, myoinvasion assessed by MRI was an independent risk factor for lymph node metastasis as well as high-grade histology, node enlargement, and high serum CA125 level.
CONCLUSION: Volume index is compatible with myometrial invasion as a factor for predicting lymph node metastasis in endometrial cancer.
© 2013.

Entities:  

Keywords:  Endometrial cancer; Lymph node metastasis; Lymphadenectomy; Risk assessment; Tumor size; Tumor volume

Mesh:

Year:  2013        PMID: 23954595     DOI: 10.1016/j.ygyno.2013.08.008

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  16 in total

1.  Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Casper Reijnen; Joanna IntHout; Leon F A G Massuger; Fleur Strobbe; Heidi V N Küsters-Vandevelde; Ingfrid S Haldorsen; Marc P L M Snijders; Johanna M A Pijnenborg
Journal:  Oncologist       Date:  2019-06-11

2.  FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?

Authors:  Andrea Papadia; Maria Luisa Gasparri; Franziska Siegenthaler; Sara Imboden; Stefan Mohr; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-11       Impact factor: 4.553

3.  Preoperative prediction of deep myometrial invasion and tumor grade for stage I endometrioid adenocarcinoma: a simple method of measurement on DWI.

Authors:  Bin Yan; Xiufen Liang; Tingting Zhao; Chen Niu; Caixia Ding; Wenjun Liu
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

4.  Estimated intermediate risk endometrial cancer: debate and new perspectives on therapy individualization and prognosis establishment starting from a peculiar case.

Authors:  Salvatore Gizzo; Alberta Fabris; Pietro Litta; Carlo Saccardi
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 5.  Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.

Authors:  Giorgio Bogani; Sean C Dowdy; William A Cliby; Fabio Ghezzi; Diego Rossetti; Andrea Mariani
Journal:  J Obstet Gynaecol Res       Date:  2014-02       Impact factor: 1.730

6.  The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer.

Authors:  Andrea Papadia; Alessandro Buda; Maria Luisa Gasparri; Giampaolo Di Martino; Beatrice Bussi; Debora Verri; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-24       Impact factor: 4.553

7.  Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.

Authors:  Sigmund Ytre-Hauge; Jenny A Husby; Inger J Magnussen; Henrica M J Werner; Øyvind O Salvesen; Line Bjørge; Jone Trovik; Ingunn M Stefansson; Helga B Salvesen; Ingfrid S Haldorsen
Journal:  Int J Gynecol Cancer       Date:  2015-03       Impact factor: 3.437

8.  Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer.

Authors:  Hyun Jin Choi; Sunyoung Lee; Byung Kwan Park; Tae Joong Kim; Chan Kyo Kim; Jung Jae Park; Chel Hun Choi; Yoo Young Lee; Jeong Won Lee; Duk Soo Bae; Byoung Gie Kim
Journal:  J Gynecol Oncol       Date:  2016-04-18       Impact factor: 4.401

Review 9.  What Is the Best Preoperative Imaging for Endometrial Cancer?

Authors:  Ingfrid S Haldorsen; Helga B Salvesen
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

10.  Less Invasive Endometrial Cancer Surgery with Extraperitoneal Pelvic and Para-aortic Lymphadenectomy via a Small Midline Abdominal Incision and the Retroperitoneal Approach.

Authors:  Shinichi Komiyama; Chiaki Takeya; Rena Takahashi; Sumito Nagasaki; Kaneyuki Kubushiro
Journal:  J Cancer       Date:  2016-04-29       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.